APA引文

Simmons, T. R., Vetter, T. A., Huang, N., Vulin-Chaffiol, A., Wein, N., & Flanigan, K. M. (2021). Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated DMD exon 2 skipping. Mol Ther Methods Clin Dev.

Citação norma Chicago

Simmons, Tabatha R., Tatyana A. Vetter, Nianyuan Huang, Adeline Vulin-Chaffiol, Nicolas Wein, and Kevin M. Flanigan. "Pre-clinical Dose-escalation Studies Establish a Therapeutic Range for U7snRNA-mediated DMD Exon 2 Skipping." Mol Ther Methods Clin Dev 2021.

MLA引文

Simmons, Tabatha R., et al. "Pre-clinical Dose-escalation Studies Establish a Therapeutic Range for U7snRNA-mediated DMD Exon 2 Skipping." Mol Ther Methods Clin Dev 2021.